To view the PDF file, sign up for a MySharenet subscription.

African Oxygen Limited - Press Release

Release Date: 02/11/2001 07:03
Code(s): AFX
Wrap Text
November 1, 2001
Afrox lifts attributable profit by 30%

Aggressive marketing initiatives, new products and focus on asset management has resulted in African Oxygen Limited (Afrox) continuing its good
performance record, with revenue up 11 percent and a 30 percent increase in net profit attributable to shareholders, for the year ended September 2001. Managing director of Afrox, Jimmy Marriott, says, "The good performance was achieved in a difficult and slowing economy, where the manufacturing sector continues to remain depressed. Nevertheless, most of Afrox's revenue comes from service sector related businesses and the company's broad business base, coupled with a high annual rental income, enables Afrox to show growth through all economic cycles. This is the 37th consecutive year that the company has shown increases in revenues and profits since listing in 1963." Growth was organic for both the Industrial gases and welding business, and the Healthcare business. New products and services also contributed to this year's growth. At the same time, several small acquisitions and joint ventures were made during the year.
"On the Industrial side," says Marriott, "we purchased a major liquefied petroleum gas distributor in Botswana, the assets of Messer / Fedgas in Namibia, concluded a joint venture with the government in Mozambique and another in Madagascar, and expanded into a further three African countries, which now gives us operations in 16 sub-Saharan countries. Healthcare bought out certain minorities in hospitals. The full effect of these acquisitions, however, will only be realised in the coming financial year." Turning to the future Marriott says that Afrox will continue to show sound organic growth with its many revenue enhancing initiatives. This, together with new initiatives and acquisitions, places the company in a good position for future growth.
Revenue, at R5,2 billion, was 11 percent higher. Operating profit before finance costs was up 18 percent at R789 million and included exceptional items of R23,8 million, which were realised from an asset closure and disposal programme. This programme also resulted in an additional cash inflow of R167 million.
Net interest paid reduced by 10 percent to R146 million (2000: R162
million). Aside from the benefit of interest rates reducing by an average 1 percent over this year, borrowings were on average R100 million lower than the previous year's levels. This was due to controlled capital expenditure and improved working capital management, following the establishment of world-class centralised service centres.
The tax rate declined from 32 percent to 29 percent during the year. This arose predominantly from an increase in exempt income following the disposal of certain assets in the Industrial business and also the utilisation of assessed losses in both businesses.
Marriott says "The excellent revenue and profit growth, however, I feel was overshadowed by prudent asset management, which has considerably enhanced the financial structure of the company."
"Cash generated from operations increased by a significant 56 percent to R982 million and excellent working capital management resulted in this area declining by R7 million during the year. Particularly noteworthy
improvements were achieved in debtor and creditor management."
The greater focus on asset efficiency resulted in an additional cash inflow of R167 million from certain disposals. The overall impact is that interest bearing borrowings have declined by R313 million or 33 percent to R634 million at the financial year-end. Gearing has declined from 50 percent to 27 percent.
Afrox's consistent growth has meant the directors have declared a final dividend of 31,5 cents per share, up by 13 percent. The total dividend of 52 cents is 11 percent higher and is covered 2 times by headline earnings per share of 104 cents. Since listing in 1963, Afrox has declared increased dividends each year, with the exception of one, which remained unchanged on the previous year. Business review
Afrox is structured along three lines of business to mirror the structure of The BOC Group plc, Afrox's parent company. This structure gives Afrox access to global best operating practices, the latest technology, and world leading management practices.
Industrial operations consist of Industrial and Special Products (ISP) comprising cylinder and liquid fabrication gases, special and medical gases, Handigas and welding products. Process Gas Solutions (PGS) is made up of large gas-producing plants, gas pipelines and bulk process gases. The Healthcare business comprises hospitals and healthcare services businesses. The gases and welding businesses (ISP and PGS) showed revenue and profit growth, and maintained market share in a very competitive environment. Significant ISP marketing initiatives led to a number of new large customers and increased retail sales though re-imaged sales centres. Handigas
continued to show volume growth and five mega bulk contracts were signed during the year. Growth was again realised in welding products exports, gaseous chemicals, and in the PGS line of business, from increased nitrogen and carbon dioxide volumes, mainly to the food and beverage industry. PGS also signed several large oxygen contracts and commissioned two hydrogen plants, which resulted in securing additional major business.
Again, Healthcare had an excellent year. The year was, however, one of consolidation, following the merger, with focus on asset management,
realising operating synergies and improving efficiencies.
Although paid patient days remained relatively flat, there was organic growth with admissions and theatre cases, both up one percent. Revenue and profits for paid patient days were up as a result of efficiencies and increased acuity levels. During the year, Afrox sold its interest in Lifecare Group Holdings Limited (Lifecare) to its subsidiary company, Afrox Healthcare Limited. This now consolidates Afrox's healthcare interest into one company in which Afrox has an 82 percent interest.
Healthcare services' operations performed well. The ground work for a number of innovative and exciting products was completed this financial year and launches will take place early in 2002. Ends Issued by African Oxygen Limited (Afrox) For further information contact:
Chris Fieldgate (Investor Relations) (011) 490-0430 or Cell: 082-495-1481

Share This Story